Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Target of RNAIII-activating protein (TRAP) is a 21 kDa membrane-associated protein in Staphylococcus aureus that has been identified as a master regulator of the bacteria's quorum-sensing and virulence pathways (Korem et al., 2003, PubMed: 12867450). According to the RAP/TRAP model, TRAP is phosphorylated in the presence of the RNAIII-activating protein (RAP), an autoinducer secreted by the bacteria as population density increases (Balaban et al., 2001, PubMed: 11158668). This phosphorylation event is described as a prerequisite for the activation of the accessory gene regulator (agr) system, which controls the expression of RNAIII and subsequent virulence factors like alpha-toxin (Gov et al., 2001, PubMed: 11274107). While the RAP/TRAP signaling model has been a subject of scientific debate regarding its integration with the canonical agr system, TRAP remains a significant target for anti-virulence drug development (Balaban et al., 2003, PubMed: 12654481). Therapeutic agents like the RNAIII-inhibiting peptide (RIP) work by competitively inhibiting the phosphorylation of TRAP, thereby suppressing toxin production (Yang et al., 2006, PubMed: 16410547). This approach aims to treat multidrug-resistant S. aureus infections by disarming the pathogen's virulence machinery rather than killing the bacteria directly.
Inhibition of TRAP phosphorylation to prevent activation of the accessory gene regulator (agr) system and subsequent virulence factor production.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Target of RNAIII-activating protein (TRAP) (TRAP).